BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Why BioCryst’s HAE Treatment Failed to Impress

Posted: May 21, 2019 at 10:10 am
Last updated: January 6, 2020 4:28 am

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema (HAE) patients. Specifically, the firm announced ...
Read Full Story »

Jefferies Says Buy These 5 Sizzling Stocks Under $10

Posted: May 11, 2019 at 8:55 am
Last updated: January 6, 2020 4:45 am

Most firms on Wall Street focus on large and mega cap stocks, as they provide a degree of safety and liquidity. Unfortunately, many investors are limited in the number of ...
Read Full Story »

Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

Posted: October 20, 2018 at 9:20 am
Last updated: January 11, 2020 4:07 pm

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they ...
Read Full Story »

BioCryst Pharmaceuticals Stock Retreats After HAE Study Results

Posted: September 4, 2018 at 9:50 am
Last updated: January 11, 2020 6:27 pm

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares fell on Tuesday after the company announced initial results from its hereditary angioedema (HAE) trial. Specifically, data that came from the ZENITH-1 trial, and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, BioCryst, Costco, Generac, Goodyear, Intel, Microsoft, Netflix and More

Posted: July 17, 2018 at 9:15 am
Last updated: January 11, 2020 8:55 pm

Stocks were marginally lower on Tuesday after investors took a bite out of the FANG stocks. Investors have had less faith and lower rewards by buying the dips in 2018 ...
Read Full Story »

BioCryst Shareholders Back Out of Idera Merger

Posted: July 11, 2018 at 11:05 am
Last updated: January 11, 2020 9:11 pm

Idera Pharmaceuticals Inc. (NASDAQ: IDRA) shares crumbled on Wednesday after BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) announced that it terminated their merger agreement. Ultimately the cause of this termination was the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Dollar General, KLA-Tencor, Micron Technology, Nike, Red Hat and More

Posted: June 22, 2018 at 8:45 am
Last updated: January 11, 2020 10:02 pm

The futures traded higher Friday morning, although it appears that the worries over trade and tariffs are still in place. This comes despite the fact that car makers in Europe ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

Posted: January 2, 2018 at 9:15 am
Last updated: January 12, 2020 4:56 am

Stocks hit all-time highs many times during 2017, and the first day of 2018 was looking to have a strong open. With the raging bull market now nearing nine years ...
Read Full Story »

Can BioCryst Turn Itself Around With This FDA Approval?

Posted: September 21, 2017 at 9:55 am
Last updated: January 12, 2020 7:57 am

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) saw its shares make a handy gain in Thursday's premarket after the firm received an update from the U.S. Food and Drug Administration (FDA). This ...
Read Full Story »

BioCryst Pharmaceuticals Announces Secondary Offering

Posted: September 12, 2017 at 10:50 am
Last updated: January 12, 2020 8:17 am

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) watched its shares fall handily on Tuesday after the firm announced a secondary offering. The company plans on selling $80 million of common stock, with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BioCryst, Exxon, FCA, HPE, IAMGOLD, Mallinckrodt, Rockwell Collins and More

Posted: September 6, 2017 at 9:10 am
Last updated: January 12, 2020 8:28 am

Stocks were indicated to open higher on Wednesday after Tuesday's strong sell-off. The indexes still remain close to all-time highs, and the one trend that has prevailed for more than ...
Read Full Story »

BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win

Posted: September 5, 2017 at 10:35 am
Last updated: January 12, 2020 8:31 am

Shares of BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) saw a handy gain on Tuesday after the company released the final results from its mid-stage APeX-1 clinical trial in hereditary angioedema (HAE). ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BioCryst, Cisco, Groupon, SunPower, Tesla, Wells Fargo and Many More

Posted: February 16, 2017 at 10:20 am
Last updated: January 12, 2020 2:46 pm

Stocks took a breather on Thursday after a strong Philadelphia Fed report and a low jobless claims report, but the markets have been hitting all-time highs. The Dow hit 20,600 and ...
Read Full Story »

8 Major Biopharma Events Coming Later in 2016 and in 2017

Posted: March 29, 2016 at 9:35 am
Last updated: January 13, 2020 11:25 am

Companies in the pharmaceutical industry generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There can be a fair amount of risk ...
Read Full Story »

4 BioPharma Movers That Cannot Be Ignored

Posted: February 13, 2016 at 10:15 am
Last updated: January 13, 2020 1:13 pm

Over the past week, a few biotech companies made absolutely massive runs, either up and down. In the past year, the health care sector was on fire from positive trials, ...
Read Full Story »